Trial of Enteric-Coated Camoquin in Intestinal Amebiasis

View More View Less


Enteric-coated Camoquin proved ineffectual in the treatment of intestinal amebiasis in 15 individuals; only 4 or 27 per cent were apparently cured even with total dosages as high as 11.4 Gm. The drug was equally ineffectual in treatment of the Trichomonas hominis that 8 of these patients harbored. Two-thirds of the patients had definite symptoms of toxicity with dizziness being the most pronounced and frequent complaint. As a result of these observations, enteric-coated Camoquin is not recommended for the treatment of intestinal amebiasis.